NHNazia Husain

Nazia Husain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nazia Husain has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Outcomes of Hypoplastic Left Heart Syndrome by Subtype and Presence of Ventriculocoronary Connections: A Fetal Heart Society Multicenter Retrospective Study

    by David M. Barris, Lindsay R. Freud, Patrick E. Day, Shaine A. Morris, Keila N. Lopez, Ann Kavanaugh-McHugh, Stacy A.S. Killen, Shabnam Peyvandi, Flora Nuñez Gallegos, Anita J. Moon-Grady, et al.

    BACKGROUND: Hypoplastic left heart syndrome (HLHS) is classified by anatomic subtype: mitral atresia and aortic atresia (MA/AA), mitral stenosis and aortic atresia (MS/AA), and mitral stenosis and aortic stenosis (MS/AS). The MS/AA subtype is associated with ventriculocoronary connections (VCCs). We assessed whether specific HLHS subtypes are associated with an increased risk of mortality and whether this risk is stratified by VCCs identified during fetal or postnatal echocardiography. We also assessed whether the type of neonatal intervention performed modified the risk. METHODS: We performed a multicenter retrospective cohort study of fetuses and infants P =0.784). CONCLUSIONS: In a large, multicenter cohort of HLHS patients, the MS/AA subtype with VCCs had the lowest TFS. Prenatal diagnosis of VCCs was associated with a lower TFS. This study underscores the prognostic value of assessing for VCCs in patients with HLHS both before and after birth.

  • Commentary: Ferumoxytol in pediatric cardiovascular imaging

    by Cynthia K. Rigsby, Andrada R. Popescu, Nazia Husain

  • Prenatal Predictors of Fetal and Neonatal Death in Truncus Arteriosus: A Fetal Heart Society Research Collaborative Study

    by Kelly Cox, Nazia Husain, Deidra Ansah, Tiffany Knight, Alexandra Channing, Bettina Cuneo, Preeta Dhanantwari, Mary Donofrio, Miwa Geiger, Lisa Howley, et al.

    Background: Fetal and neonatal outcomes and factors increasing mortality risk in fetal truncus arteriosus are not well characterized. We aimed to examine the prenatally encountered cardiac spectrum, define extracardiac and genetic associations, explore clinical outcomes and identify prenatal factors associated with worse outcomes in a contemporary large cohort. Methods: A multicenter retrospective cohort study was conducted via the Fetal Heart Society Research Collaborative including fetal truncus arteriosus cases encountered between January 1, 2010, and September 1, 2021, within 22 North American cardiac centers. Demographic, clinical, anatomic, and functional fetal echocardiographic variables were analyzed for associations with presurgical death (fetal death/neonatal presurgical death/neonatal listing for heart transplantation before initial hospital discharge). Variables were compared between survivors and nonsurvivors with nonparametric tests and univariable logistic regression; a multivariable linear probability model was used for further assessment after adjusting for confounders. Results: Of 378 fetuses diagnosed prenatally, 201 (53.2%) had a genetic abnormality or extracardiac anomaly identified. Pregnancy termination was chosen in 47 (12.4%) pregnancies and palliative care in 13 (3.4%). Of 318 pregnancies with intention to treat, 17 (5.3%) ended in fetal death and 19 (6%) in neonatal presurgical death. In addition to prematurity and low birth weight, truncal valve stenosis (but not regurgitation or anatomic subtype) and ventricular dysfunction were associated with presurgical death. Conclusions: Half of fetuses with truncus arteriosus will have an associated genetic abnormality or extracardiac anomaly. Truncal valve stenosis and ventricular dysfunction, as well as preterm birth and low birth weight, are associated with presurgical death. These data are important for prognostication and prenatal counseling.

  • Open Access

    Six-Minute Activity-95th Centile, a Novel Wearable-Derived Clinical Outcome Assessment for Duchenne Muscular Dystrophy

    by Nicholas Joy, Jonathan Soslow, W. Bryan Burnette, Andrew Liu, Christine C. Guo, Rakesh Pilkar, James C. Slaughter, Meng Xu, Kimberly Crum, Karry Su, et al.


  • Open Access

    Introduction to the Topical Collection on Pediatric Cardiovascular Imaging

    by Cara E. Morin, Nazia Husain, Monica Epelman

  • In defense of the dyad — a commentary

    by Nazia Husain, Deidra A. Ansah, Andrada Popescu, Joshua D. Robinson, Cynthia K. Rigsby

  • Boys With Duchenne Muscular Dystrophy Have Diastolic Dysfunction Based on CMR

    by Joseph R. Starnes, Jeffrey G. Weiner, Kristen George-Durrett, Kimberly Crum, Christopher C. Henderson, M. Jay Campbell, Katheryn Gambetta, Kan N. Hor, Nazia Husain, Jennifer S. Li, et al.

    BACKGROUND: Cardiomyopathy is the leading cause of death in boys with Duchenne muscular dystrophy (DMD). While cardiac magnetic resonance (CMR) is routinely used to assess fibrosis and left ventricular (LV) ejection fraction, CMR measures of LV filling and ejection in DMD have not been reported. METHODS: Patients with DMD (n=179) and healthy controls (n=96) were prospectively enrolled and underwent CMR. The DMD cohort was followed clinically at multiple institutions, and clinical data were recorded. Standard volumes and functions were calculated, and LV filling and ejection curves were measured from baseline CMR. Multivariable linear regressions were used to compare ventricular filling and ejection measures between groups, adjusting for baseline differences. Cox regressions were used to evaluate the relationship between diastolic function measures and mortality in the DMD cohort. RESULTS: Patients with DMD had significantly smaller stature and ventricular volumes than healthy control patients ( P P P P P =0.011). When adjusted for heart rate, a lower peak ventricular ejection rate ( P =0.007) and peak filling rate ( P =0.033), normalized to LV end-diastolic volume, were associated with mortality in patients with DMD. CONCLUSIONS: Patients with DMD have significantly different baseline CMR filling and ejection indices compared with controls. Some filling indices are associated with mortality and may be useful prognostic measures. Further research is needed in larger cohorts to determine the prognostic value of these differences.


  • Pediatric Cardiovascular Magnetic Resonance Imaging

    by Simon Lee, Nazia Husain, Lindsey Griffin, Cynthia K. Rigsby, Joshua D. Robinson

  • Open Access

    Rate of Change in Cardiac Magnetic Resonance Imaging Measures Is Associated With Death in Duchenne Muscular Dystrophy

    by Joseph R. Starnes, Meng Xu, Kristen George‐Durrett, Kimberly Crum, Frank J. Raucci, Christopher F. Spurney, Kan N. Hor, Linda H. Cripe, Nazia Husain, Sujatha Buddhe, et al.

    Background: Cardiovascular disease is the leading cause of death among patients with Duchenne muscular dystrophy (DMD). Identifying patients at risk of early death could allow for increased monitoring and more intensive therapy. Measures that associate with death could serve as surrogate outcomes in clinical trials. Methods and Results: Duchenne muscular dystrophy subjects prospectively enrolled in observational studies were included. Models using generalized least squares were used to assess the difference of cardiac magnetic resonance measurements between deceased and alive subjects. A total of 63 participants underwent multiple cardiac magnetic resonance imaging and were included in the analyses. Twelve subjects (19.1%) died over a median follow‐up of 5 years (interquartile range, 3.1–7.0). Rate of decline in left ventricular ejection fraction was faster in deceased than alive subjects ( P P =0.0132) and systolic ( P P =0.049) while no difference in global circumferential strain was seen. The rate of increase in late gadolinium enhancement, base T1, and mid T1 did not differ between groups. Conclusions: Duchenne muscular dystrophy death is associated with the rate of change in left ventricular ejection fraction, midcircumferential strain, and ventricular volumes. Aggressive medical therapy to decrease the rate of progression may improve the mortality rate in this population. A decrease in the rate of progression may serve as a valid surrogate outcome for therapeutic trials.


  • Pediatric Cardiovascular Magnetic Resonance Imaging

    by Simon Lee, Nazia Husain, Lindsey Griffin, Cynthia K. Rigsby, Joshua D. Robinson